 |
IP Impact 2005
Intellectual Property Gets Down to Business
Conference
Session Description
9:00 AM - 10:00 AM
HOW TO ASSESS EARLY-STAGE VENTURE CAPITAL INVESTMENTS BASED ON IP PORTFOLIO
QUALITY
Moderator:
Andrew Ramer, Ocean Tomo
This session presents new research on historical venture capital performance
from the perspective of IP portfolio quality. A distinguished panel of
venture capitalists will discuss and debate their strategies and methodologies
for assessing, valuing and maximizing their portfolio companies' intellectual
property before and after investing. The panel will provide valuable insights
to entrepreneurs on how to structure early IP strategies to maximize IP
value, strategically expand their IP portfolio and generate investor interest.
10:00 AM - 10:15 AM
BREAK
10:15 AM - 11:15 AM
REALIZING THE VALUE OF INTANGIBLE ASSETS: USING IP TO EXPEDITE ACQUISITION
AND OTHER EXIT STRATEGIES
Featured Speakers:
Peter Rule, EKOS Corporation, OptiScan Biomedical Corporation
Richard Ferrari, De Novo Ventures
Mir Imran, DFJ ePlanet
Michael Jaro, Medtronic Vascular, Inc.
Patents can open doors to partnerships and exit strategies that are often
reserved for more mature, established market players. When investors look
at a company and its IP, what do they see? What drives M&A deals,
and what drives them away? How does a company position itself to be acquired?
A panel discussion will explore which patent strategies add the most value
to early-stage companies, and how a well-executed patent portfolio can
become a primary component in valuing a company for acquisition.
11:15 AM - 11:30 AM
BREAK
11:30 AM - 12:30 PM
THE PROS AND CONS OF INVESTING IN COMPANIES IN LITIGATION: WHEN TO TALK
AND WHEN TO WALK
Featured Speakers:
Robert Kramer, Altitude Capital Partners
Ed Treska, Acacia Technology Group
Matt Mosman, Levanta, Inc.
John Amster, Intellectual Ventures
Stephen Jensen, Knobbe Martens Olson & Bear
Anticipating a rise in IP litigation, patent owners are more active than
ever in enforcing their IP rights in court. How does an investor determine
when a company in litigation is viable and when the potential return is
not worth the risk? What do investors consider in their decisions to target
plaintiff or defendant companies for investment, and how can acquiring
a company in litigation be beneficial? A panel of IP litigators, entrepreneurs
and investors will address why more companies are litigating as well as
the risks and opportunities of investing in companies that are in litigation.
12:30 PM - 2:00 PM
LUNCH
Understanding the new patent reform proposal
Keynote Speaker:
Michael Kirk, American Intellectual Property Law Association
2:00 PM - 3:00 PM
IP NEWS YOU NEED TO KNOW
Moderator:
William Bunker, Knobbe Martens Olson & Bear
This session will provide a round-up of some of the latest IP industry
headline news, with an emphasis on the medical device, biotech and electronic
industries. Panelists will share their thoughts on the new patent legislation
reform. They will also discuss recent IP-related cases, deals and trends
such as the Michelson settlement, ongoing patent litigation between major
industry players, the battle among judges over the biotech written description
requirement and the growing concerns with open source licensing. Stay
in tune with what's happening in your industry and learn valuable lessons
from the experiences of others.
3:00 PM - 3:30 PM
BREAK
3:30 PM - 4:30 PM
DON'T THROW YOUR MONEY AWAY: POST-INVESTMENT AND ACQUISITION STRATEGIES
Featured Speakers:
Philip Hartstein, Ocean Tomo
Sabing Lee, Knobbe Martens Olson & Bear
After an investment or acquisition is completed, what should the target
company do to maximize return on the investment? How much money should
be spent on IP, and how should the company plan for and allocate its IP-related
expenses? Experts on IP portfolio management will share their advice on
how a company can create, budget for and manage an effective IP business
plan post-investment or acquisition
Click
here to register for this seminar
Registration Fee $295.00
|